XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.73−0.05 (-2.81%)
Close on Nov 18, 2026Market cap $52.74MP/E –Yield –
XBiotech free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
XBiotech's free cash flow for the twelve months ending Jun 30, 2026 was -$40.84M. For fiscal 2025 it was -$40.21M. The highest annual figure on record is $65.92M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$40.21M | – |
| FY2024 | Dec 31, 2024 | -$32.27M | – |
| FY2023 | Dec 31, 2023 | -$19.09M | – |
| FY2022 | Dec 31, 2022 | -$15.41M | -123.4% |
| FY2021 | Dec 31, 2021 | $65.92M | – |
| FY2020 | Dec 31, 2020 | -$68.88M | – |
| FY2019 | Dec 31, 2019 | -$18.47M | – |
| FY2018 | Dec 31, 2018 | -$16.66M | – |
| FY2017 | Dec 31, 2017 | -$35.05M | – |
| FY2016 | Dec 31, 2016 | -$50.76M | – |
| FY2015 | Dec 31, 2015 | -$35.63M | – |
| FY2014 | Dec 31, 2014 | -$13.10M | – |
| FY2013 | Dec 31, 2013 | -$8.97M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.52M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.97M | – |
| Q4 FY2025 | Dec 31, 2025 | -$22.99M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.37M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.04M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.81M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.62M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.18M | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.00M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.46M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.55M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.52M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.21M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.81M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.30M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.36M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.47M | -107.7% |
| Q1 FY2022 | Mar 31, 2022 | -$5.28M | -550.9% |
| Q4 FY2021 | Dec 31, 2021 | -$2.24M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.10M | -160.4% |
| Q2 FY2021 | Jun 30, 2021 | $71.09M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.17M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.61M | – |
| Q3 FY2020 | Sep 30, 2020 | $6.79M | – |
| Q2 FY2020 | Jun 30, 2020 | -$11.99M | – |
| Q1 FY2020 | Mar 31, 2020 | -$61.06M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.75M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.15M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.89M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.68M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.12M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.03M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.95M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.56M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.06M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.73M | – |
| Q2 FY2017 | Jun 30, 2017 | -$8.75M | – |
| Q1 FY2017 | Mar 31, 2017 | -$12.52M | – |
| Q4 FY2016 | Dec 31, 2016 | -$13.33M | – |
| Q3 FY2016 | Sep 30, 2016 | -$15.63M | – |
See a number that looks wrong?